Attached files
| file | filename |
|---|---|
| EX-31.2 - CERTIFICATION - Diffusion Pharmaceuticals Inc. | restorgenex_10k-ex3102.htm |
| EX-14 - ETHICS POLICY - Diffusion Pharmaceuticals Inc. | restorgenex_10k-ex14.htm |
| EX-31.1 - CERTIFICATION - Diffusion Pharmaceuticals Inc. | restorgenex_10k-ex3101.htm |
| EX-32.1 - CERTIFICATION - Diffusion Pharmaceuticals Inc. | restorgenex_10k-ex3201.htm |
| EX-32.2 - CERTIFICATION - Diffusion Pharmaceuticals Inc. | restorgenex_10k-ex3202.htm |
| 10-K - ANNUAL REPORT - Diffusion Pharmaceuticals Inc. | restorgenex_10k-123113.htm |
Exhibit 99.1
Temporary Hardship Exemption
In accordance with the temporary hardship exemption provided by Rule 201 of Regulation S-T, the date by which the interactive data file is required to be submitted has been extended by six business days.